The Asian Pacific Association for the Study of the Liver (APASL) will host the APASL Oncology 2022 meeting “Liver Cancer: Clinical and Basic Research” September 1-3, 2022. LamKap Bio gamma is very pleased to present for the first time preclinical data on the development of NILK-2501 (GPC3xCD3) and NILK-3801 (GPC3xCD28) bispecific antibodies for immunotherapy of patients with glypican-3 (GPC3) expressing solid tumors.
“Novel GPC3xCD3 (NILK-2501) and GPC3xCD28 (NILK-3801) κλ bispecific antibodies for next generation immunotherapy of GPC3-expressing cancer” will be presented on September 3 between 9:10-10:40 am JST (presentation no. WS27-2).
JR Hotel Clement Takamatsu
1-1 Hamano-cho, Takamatsu-city, Kagawa 760-0011, Japan
